Global Agrigenomics Market (2021 to 2026) - Rising Opportunities for DNA Sequencing in Crops and Livestock
24 Jun 2021
Gene Therapy
Dublin, June 24, 2021 (GLOBE NEWSWIRE) -- The "Global Agrigenomics Market by Application (Crops and Livestock), Sequencer Type (Sanger Sequencing, Illumina HiSeq Family, PacBio Sequencer, SOLiD Sequencer), Objectives, and Region (North America, Europe, APAC, South America, RoW) - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
The global agrigenomics market is estimated to be USD 3.3 billion in 2021 and is projected to reach USD 5.3 billion by 2026, at a CAGR of 9.7% from 2021 to 2026.
The agrigenomics market is increasingly driven by technological advancements in systems & services of applied genomics, demonstrable increase in the efficiency and productivity of current agricultural practices, greater availability of reference genomes, and utilization of genotyping for genome-wide association studies, genomic prediction, and cultivation of gene-edited elite cultivars with desirable traits, such as high yield, stress tolerance and pest resistance along with high milk and meat yields, better health, and increased productivity in case of livestock.The large-scale genetic characterization in some of the commercially relevant crops has provided a framework that is applicable to other crops as well. With the mounting dual challenges of population growth and climate change, new strategies, including genetic advancements, must be available to producers to address concerns of yield optimization and food security.The market for livestock is projected to grow at the highest CAGR between 2021 and 2026The livestock segment is projected to gain further growth traction during the forecast period owing to rapid adoption and commercialization of the novel genotyping platforms and related techniques such as marker-based selection (MAS) and marker-based breeding (MAB) to identify complex inheritance traits.
The global demand for animal-based food products is expected to increase by 70% by 2050. The implementation of advanced genetic technologies in livestock production will ensure minimal environmental impact with optimized animal health & fertility.A shift from traditional animal breeding to genomic selection is estimated with the introduction of genome analysis tools. The presence of next-generation sequencers has enabled researchers to quickly and effectively determine the single nucleotide polymorphisms associated with commercially important phenotypic traits and estimate the breeding value (EBV) at an earlier stage of young animals.The Marker-assisted selection by objective is projected to grow at the highest CAGR between 2021 and 2026The Marker-assisted selection is expected to grow at the highest rate during the forecast period as it is cheaper and faster than any conventional phenotypic assays, depending on the trait. Marker-assisted selection or marker-aided selection (MAS) is an indirect selection process where a trait of interest is selected based on a marker (morphological, biochemical, or DNA/RNA variation) linked to a trait of interest (e.g., productivity, disease resistance, abiotic stress tolerance, and quality), rather than on the trait itself.
This process has been extensively researched and proposed for plant and animal breeding. It uses conventional breeding approaches and does not involve transgenic approaches. Marker-assisted breeding uses DNA markers associated with desirable traits to select a plant or animal for inclusion in a breeding program early in its development. This approach dramatically reduces the time required to identify varieties or breeds which express the desired trait in a breeding program.
The marker may be the sequence of the gene that determines the trait, but in most cases, it is a DNA sequence which is located very close to the gene of interest and is therefore always inherited with the trait. Desirable traits include disease resistance, salt tolerance, and high yield. Hence, DNA markers have enormous potential to improve the efficiency and precision of conventional plant breeding via marker-assisted selection.Illumina HiSeq Family by sequencer type is projected to grow at the highest CAGR between 2021 and 2026The Illumina HiSeq Family held the largest share in 2020 and is also expected to grow at the highest rate as it is an efficient ultra-high-throughput sequencing system that supports the broadest range of applications and study sizes. Based on sequencer type, Illumina HiSeq Family led the agrigenomics market, exhibiting a significant share of in 2020, registering a value of USD 1,393.2 million. It is also the most widely utilized next-generation sequencing (NGS) technology owing to its high throughput and exceptional operational performance. It also exhibits greater sensitivity to detect low-frequency gene variants.
PacBio and solid sequencers are also expected to exhibit decent growth rates during the forecast period. Sequencing by ligation (SOLiD) utilizes DNA ligase, an enzyme widely used in biotechnology for its ability to ligate double-stranded DNA strands - owing to its two-base sequencing method, it is the most accurate and economical second-generation sequencing platform.The agrigenomics market in the Asia Pacific region is projected to grow at the highest CAGR during the forecast periodThe Asia Pacific region is projected to be the fastest-growing in the global agrigenomics market at a CAGR of 10.6%. The growth in the region is projected due to the progress in research and development activities in India, China, and Japan. The availability of high-quality reference genome sequences for a majority of crops has strengthened the foundation of functional genomics in the region.
Asia Pacific is the most populous continent with growing concerns for food and nutritional security. The region also produces important food crops such as rice, wheat, barley, chickpea, and pigeon pea. The agrigenomics solutions adopted in a full-fledged manner across the key markets of the region can emerge as a strong tool in the attainment of zero hunger as a sustainable development goal.Key Topics Covered:
1 Introduction
2 Research Methodology3 Executive Summary4 Premium Insights4.1 Brief Overview of the Agrigenomics Market4.2 Agrigenomics, by Sequencer Type, 2021 Vs. 2026 (USD Million)4.3 Agrigenomics Market, by Application and Region4.4 Agrigenomics Market, by Objective4.5 North America: Agrigenomics Market, by Application and Country, 20204.6 COVID-19 Impact On the Agrigenomics Market
5 Market Overview5.1 Introduction5.2 Market Dynamics5.2.1 Drivers5.2.1.1 Advanced tools and techniques of genome analysis are at the forefront of the agrigenomics growth momentum5.2.1.2 Robust growth in grants & funding initiatives propelling agrigenomics growth5.2.2 Restraints5.2.2.1 Sub-optimized multidisciplinary research approaches and lackluster infrastructure support5.2.2.2 Public perceptions and regulatory barriers for genome editing in agriculture5.2.3 Opportunities5.2.3.1 Agrigenomics for food & nutritional security and food safety & authenticity5.2.3.2 Rising opportunities for DNA sequencing in crops and livestock5.2.4 Challenges5.2.4.1 Technological constraints of applied genetics in agriculture5.3 Impact of COVID-19 On Market Dynamics5.3.1 COVID-19 Negatively Impacted the Supply Chain and Revenue Streams of the Agrigenomics Market
6 Industry Trends6.1 Introduction6.2 Value Chain Analysis6.3 Technology Analysis6.3.1 Polymerase Chain Reaction (PCR)6.3.2 Quantitative PCR6.3.3 SeqSNP6.3.4 AgRenSeq6.3.5 Microarray Technology6.4 Supply Chain Analysis6.5 Ecosystem & Market Map6.5.1 Upstream6.5.2 Downstream6.5.2.1 Regulatory bodies6.6 Porter's Five forces Analysis6.6.1 Threat of New Entrants6.6.2 Threat of Substitutes6.6.3 Bargaining Power of Suppliers6.6.4 Bargaining Power of Buyers6.6.5 Degree of Competition6.7 YC-YCC Shift6.8 Patent Analysis6.9 Case Studies6.9.1 Case Study 16.9.2 Case Study 2
7 Regulatory Framework
8 Agrigenomics Market, by Application
9 Agrigenomics Market, by Objective
10 Agrigenomics Market, by Sequencer Type
11 Agrigenomics Market, by Region
12 Competitive Landscape
13 Company Profiles13.1 Key Players13.1.1 Eurofins Scientific13.1.2 Agilent Technologies, Inc.13.1.3 Thermo Fisher Scientific, Inc.13.1.4 LGC Limited13.1.5 Illumina, Inc.13.1.6 Zoetis13.1.7 Neogen Corporation13.1.8 GalSeq Srl13.1.9 Biogenetic Services, Inc.13.1.10 Daicel Arbor Biosciences13.2 Start-Ups/SMEs13.2.1 Tecan Genomics, Inc13.2.2 Genotypic Technology Pvt Ltd13.2.3 BGI Genomics13.2.4 Genewiz13.2.5 Tiangen Biotech (Beijing) Co., Ltd.13.2.6 Nucleome Informatics Pvt Ltd13.2.7 IGA Technology Services13.2.8 ArrayGen Technologies Pvt. Ltd.13.2.9 LC Sciences, Llc13.2.10 CD Genomics
14 Adjacent & Related Markets
15 Appendix
For more information about this report visit
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.